Erich Maximilian Platzer

Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany.

Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation.

HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds.

Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec® Histology kit and CINtec® Cytology kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4™ antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results. mtm laboratories AG also has programs to identify and develop biomarker based diagnostics for other cancer indications. With its extensive and ever increasing network of clinical research institutions, academic research organizations, and medical professionals active in the field of oncology and molecular pathology, mtm has established a rapid, integrated process for the successful identification and clinical validation of molecular markers associated with cancer.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany.

credentis ag designs, develops, manufactures, and markets dental devices. The firm offers CURODONT. The company was founded by Dominik A. Lysek in January 2010 and is headquartered in Windisch, Switzerland.

StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland.

YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland.

Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland.

Leman Micro Devices SA engages in the development of sensor and software systems that measures blood pressure, body temperature, blood oxygen saturation, heart rate and respiration rate in smartphone. The company was founded by Chris Elliott and Mark-Eric Jones in 2010 and is headquartered in Lausanne, Switzerland.

Bio-Bac, Inc. specializes in biological treatment of organic waste through a bacterial bioaugmentation process. Its solutions include wastewater treatment, nitrification – ammonia degradation, ponds and water gardens, golf, hydrocarbons, household and commercial and agricultural treatment. The company is headquartered in Sherbrooke, Canada.

Peripal AG engages in the development and commercialization of aid for the dialysis. It offers PeriSafe a novel patient assist device for the safe and easy connection in Peritoneal Dialysis. The company was founded by Sandra Neumann in 2015 and is headquartered in Zurich, Switzerland.

MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland.

BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland.

AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland.